James S Partyka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- You will find I'm a multifaceted pharmaceutical professional and innovator with a proven record of successes spanning the Pharmaceutical, Biotechnology, Hospital and Academic Industries; with over 20 years immuno-oncology patient care, teaching, clinical research, and medical affairs experience; knowledge in writing clinical research and regulatory documents. I have a broad background in financial reporting with budget preparations, managing monthly and annual spend. I've been successful in trial management delivering high quality results within budget and I'm proficient in medical writing for protocols, informed consents, INDs, study reports, presentations and manuscripts.
I was the Founding Director of the Clinical Trials Office and the Oncology Pharmacy Residency program at H. Lee Moffitt Cancer Center in Tampa, Florida.
I am a Board Certified Pharmacotherapy Specialist (BCPS) and a Registered Pharmacist in the state of Florida.
A few of my key accomplishments include:
★ Clinical Lead for the Marketing Authorization Application and the successful approval of Adcetris (brentuximab vedotin)
★ Founder of Pharmative, a Global Medical Communications Company for Patients, Scientists and Healthcare Professionals
★ Global Publication Lead for Nexavar (sorafenib)
★ Clinical research and / or product commercialization support for cabozantinib, CC-122, neratinib, brentuximab vedotin, TAK-441, sorafenib, motesanib, panitumumab, pegfilgrastim, filgrastim, darbepoetin alfa, palifermin, romiplostim, denosumab, and topotecan.
Education & Training
- The University of Texas at AustinPharmD, 1989
- University of Texas M.D. Anderson Cancer CenterResidency
- University of ConnecticutBA/BS in Pharmacy
Awards, Honors, & Recognition
- Employee of the Year Millenium, 2012
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Publications & Presentations
Journal Articles
- Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid TumorsGoldman J, Partyka JS, Clinical Cancer Research, 3/2015
- Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic CorrelatesPerkins J, Partyka JS, Clinical Cancer Research, 12/2011
External Links
- Pharmativehttp://www.Pharmative.com
Office
1280 S Gene Autry Trail
Palm Springs, CA 92264
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: